跳至主要内容
临床试验/NCT06937125
NCT06937125招募中不适用

Evaluation of Valvular Heart Disease: Multicenter Registry of Noninvasive Imaging Modalities by Cardiac CT

Toho University1 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2025年3月12日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
350
试验地点
1
主要终点
the 1-year composite endpoint of all-cause death and major cardiac adverse events (MACE) including VHD intervention.

研究概览

简要总结

The EVIDENTIA Registry is a multicenter study designed to evaluate valvular heart disease (VHD) using cardiac CT. It aims to assess cardiac valve anatomy, function, and myocardial characteristics through detailed CT analysis.

  1. Assessing the accuracy of cardiac CT in evaluating cardiac structure, volume, function, and myocardium in VHD patients.
  2. Comparing the severity, classification, and etiology (primary vs. functional) of VHD.
  3. Monitoring serial changes in VHD severity via echocardiography.
  4. Investigating the relationship between echocardiographic and CT-derived parameters.
  5. Examining the correlation between imaging findings, VHD interventions, and patient prognosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with at least moderate valvular heart disease who had a cardiac CT with 64 or more rows
  • 18 years of age or older

排除标准

  • Less than 18 years old
  • Acute VHD
  • Infectious endocarditis
  • Patients with post-VHD intervention
  • Poor CT image quality for analyzing CT data.

结局指标

主要结局

the 1-year composite endpoint of all-cause death and major cardiac adverse events (MACE) including VHD intervention.

时间窗: one year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hideki Koike

Principal Investigator

Toho University

研究点 (1)

Loading locations...

相似试验